Motto International Corp recalls Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper packaging, packa…

Recall date

December 17, 2019

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0655-2020

FDA classification

Class I

Brand / firm

Motto International Corp

Sold / distributed

TX

Why it was recalled

Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper packaging, packaged in 2, 4, 10 count blister cards, Motto International, Dallas, TX